Immunohistochemistry (IHC) analysis revealed expression of multiple markers such as CD31, CD34, MPO, LCA, CD99, CD117, and Ki-67(+50%+), leading to the diagnosis of MS. The gene discussed is PECAM1; the disease is myeloid sarcoma.